CommercialCoverageMedium impact
Update to Member Cost Sharing for Treatment of COVID-19
CareFirst BlueCross BlueShield·Provider News
Effective date
Sep 1, 2021
We identified it
Jun 20, 2026
Summary
Effective September 1, 2021, CareFirst BlueCross BlueShield will resume charging members cost-sharing (copays, coinsurance, deductibles) for most COVID-19 treatments, but will continue to waive member costs specifically for monoclonal antibody treatments. COVID-19 vaccinations remain at zero cost share.
Action Required
Immediately: Billing team must update patient financial counseling scripts to inform CareFirst commercial members that cost-sharing now applies to most COVID-19 treatments except monoclonal antibody therapy. Update front desk staff to collect copays/deductibles for COVID treatment visits. Verify eligibility and benefits via CareFirst Direct or provider service number before COVID treatment appointments.